Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

NCT01169298

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • National Kyusyu Cancer Center Fukuoka, Japan
  • Imamura Bun-in Hospital Kagoshima, Japan
  • Kumamoto University Hospital Kumamoto, Japan
  • Nagasaki University Hospital Nagasaki, Japan
View Trial Details
Completed

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

NCT00761722

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +26 more
Locations
  • California Cancer Care Inc Greenbrae, California, United States
  • Main Cancer Centers of Florida, P.A. Ocoee, Florida, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Completed

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

NCT01351935

Conditions
B Cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations
  • Clearview Cancer Institute Oncology Specialties, P.C Huntsville, Alabama, United States
  • University of Arizona SPORE Tucson, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 13 locations
View Trial Details
Completed

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

NCT00419250

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 35 locations
View Trial Details

Related conditions